COGNITIVE / DIRECT CATALOG PRICING
Semax
Semax is the synthetic heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP), comprising an ACTH(4-7)-related sequence followed by Pro-Gly-Pro.
- Format
- Lyophilized research vial
- Listed formats
- 2
- Available now
- 2
- Catalog class
- Cognitive
Pricing, availability, quantity tiers, and member eligibility are checked again when an order is submitted.
TECHNICAL OVERVIEW
Identity first, claims kept in scope.
Semax is the synthetic heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP), comprising an ACTH(4-7)-related sequence followed by Pro-Gly-Pro.
The cognitive classification supports catalog navigation; it does not establish efficacy, safety, approval, human use, or equivalence to a material used in a cited study.
SPECIFICATIONS
- Material class
- Cognitive
- Physical format
- Lyophilized vial
- Research status
- Research purposes only
- Commerce status
- 2 formats currently orderable
PLAIN-LANGUAGE RESEARCH SNAPSHOT
What researchers have actually studied.
Semax is the synthetic heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP), comprising an ACTH(4-7)-related sequence followed by Pro-Gly-Pro.
- Research covered
- A 110-participant Russian clinical study evaluated Semax during early or late rehabilitation after ischemic stroke and reported changes in plasma BDNF and functional measures. Separate rat focal-ischemia studies measured neurotrophin, VEGF-family, and broader transcriptional responses after Semax exposure.
- Important limit
- The human evidence identified here is condition-specific, from a limited regional literature, and does not establish general cognitive effects. Rat molecular studies cannot establish human outcomes. The catalog name does not by itself analytically verify the sequence or purity of a supplied vial.
FACTUAL FAQ
Semax catalog questions
What formats are currently listed?
10 mg, 25 mg. Current price and stock state appear above.
What did researchers study?
A 110-participant Russian clinical study evaluated Semax during early or late rehabilitation after ischemic stroke and reported changes in plasma BDNF and functional measures. Separate rat focal-ischemia studies measured neurotrophin, VEGF-family, and broader transcriptional responses after Semax exposure.
What is the most important evidence limit?
The human evidence identified here is condition-specific, from a limited regional literature, and does not establish general cognitive effects. Rat molecular studies cannot establish human outcomes. The catalog name does not by itself analytically verify the sequence or purity of a supplied vial.
How should this listing be interpreted?
It is a research-material catalog listing, not medical guidance, a dosage recommendation, a safety or efficacy claim, or evidence of regulatory approval.
Where can I review related scientific references?
Use the PSC research library to locate general and compound-related source material. Open related research references →
